Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2007. Start Trial.
Date Value
September 30, 2026 -7.839M
June 30, 2026 -8.628M
March 31, 2026 -8.040M
December 31, 2025 -7.843M
September 30, 2025 -8.263M
June 30, 2025 -8.159M
March 31, 2025 -6.800M
December 31, 2024 -7.202M
September 30, 2024 -6.580M
June 30, 2024 -6.928M
March 31, 2024 -6.861M
December 31, 2023 -6.552M
September 30, 2023 -7.343M
June 30, 2023 -7.424M
March 31, 2023 -10.52M
December 31, 2022 -14.14M
September 30, 2022 -15.09M
June 30, 2022 -15.49M
March 31, 2022 -13.70M
December 31, 2021 -14.02M
September 30, 2021 -11.51M
June 30, 2021 -10.23M
March 31, 2021 -9.275M
December 31, 2020 -5.157M
September 30, 2020 -6.162M
Date Value
June 30, 2020 -7.188M
March 31, 2020 -7.727M
December 31, 2019 -8.328M
September 30, 2019 -7.658M
June 30, 2019 -6.580M
March 31, 2019 -5.804M
December 31, 2018 -4.486M
September 30, 2018 -3.902M
June 30, 2018 -3.662M
March 31, 2018 -3.400M
December 31, 2017 -3.391M
September 30, 2017 -3.220M
June 30, 2017 -2.308M
March 31, 2017 -1.651M
December 31, 2016 -0.9577M
September 30, 2016 -0.4229M
June 30, 2016 -0.3883M
March 31, 2016 -1.056M
December 31, 2015 -1.668M
September 30, 2015 -1.647M
June 30, 2015 -1.621M
March 31, 2015 -1.491M
December 31, 2014 -0.8175M
September 30, 2014 -0.7318M
June 30, 2014 -0.6293M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Liquidia Corp. 291.15M
Johnson & Johnson 19.98B
Eli Lilly & Co. 11.69B
Merck & Co., Inc. 14.75B
ANI Pharmaceuticals, Inc. 199.91M